26 Nov

Retirement of Greg Tweedly from the Board

dorsaVi Ltd | ABN: 15 129 742 409 86 Denmark St reet , Kew, VIC 3101 1800 367 728 | dorsaVi.com 26 th November 2021 Retirement of Greg Tweedly from the Board Melbourne, Australia, 26 th Novem ber 2021: dorsaVi (ASX: DVL) ( dorsaVi or the Company ) confirms that as previously advised to the market in September 2021, Mr Greg Tweedly will retire today as a Director of dorsaVi . Mr Tweedly joined the Board in October 2013 and was Chairman of the Audit and Risk Committee ( Committee ) until the retirement of Mr Herb Elliott in November 2017. Mr Tweedly resigned as Chairman of the Committee following Mr Elliott’s retirement and became Chairman of the Board. The Board and staff of dorsaVi thank Mr Tweedly for his significant leadership and tireless contribution to dorsaVi over the 8 years he has served as a director of the Company and Company Chairman . The Company commenced a Board renewal pro gram following notice of Mr Tweedly’s intention to retire and will keep shareholders updated once a suitable candidate has been appointed . This announcement has been approved by the Board of dorsaVi . – ENDS – For further information about dorsaVi, please contact: Company Investor s Andrew Ronchi Dean Dribbin Chief Executive Officer Vesparum Capital +61 417 882 267 +61 3 8582 4800 Email: ar@dorsavi.com Email: dorsavi@vesparum.com About dorsaVi dorsaVi Ltd (ASX: DVL) is an ASX c ompany focused on developing innovative motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety. dorsaVi believes its wearable sensor technology enables, for the first time, many aspects of detailed human movement and position to be accurately captured, quantified, and assessed outside a biomechanics lab, in both real - time and real situations for up to 24 hours. dorsaVi’s focus is on two major markets: • Workplace: dorsaVi enables employers to assess risk of injury for employees as well as test the effectiveness of proposed changes to OHS workplace design, equipment or methods based on objective evidence. dorsaVi works either directly with major corporations, or through an insurance company’s customer base with the aim of reducing workplace compensation and claims. dorsaVi has been used by major corporations includin g Sodexo, London Underground, Vinci Construction, Crown Resorts, Caterpillar (US), Monash Health, Coles, Woolworths, Toll, Toyota, Orora (formerly Amcor) and BHP Billiton. dorsaVi Ltd | ABN: 15 129 742 409 86 Denmark St reet , Kew, VIC 3101 1800 367 728 | dorsaVi.com • Clinical : dorsaVi is transforming the management of patients with its clinical solutions (ViMove, ViMove2 and Professional Suite) which provide objective assessment, monitoring outside the clinic and immediate biofeedback. The clinical market is broken down into physical therapy (physiotherapists), hospital in the home and e lite sports. Hospital in the home refers to the remote management of patients by clinicians outside of physical therapy (i.e. for orthopaedic conditions). dorsaVi’s Telehealth provides a virtual clinic , enabling clinicians to do business differently and ta ke their patient consultations online. Elite sports refers to the management and optimisation of athletes through objective evidence for decisions on return to play, measurement of biomechanics and immediate biofeedback to enable peak performance. Furth er information is available at www.dorsavi.com
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Dorsavi Ltd (ASX:DVL) when you join Listcorp.